Iman Satti

9.3k total citations
43 papers, 1.1k citations indexed

About

Iman Satti is a scholar working on Infectious Diseases, Immunology and Epidemiology. According to data from OpenAlex, Iman Satti has authored 43 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 33 papers in Infectious Diseases, 30 papers in Immunology and 20 papers in Epidemiology. Recurrent topics in Iman Satti's work include Tuberculosis Research and Epidemiology (32 papers), Immune responses and vaccinations (20 papers) and Immunodeficiency and Autoimmune Disorders (17 papers). Iman Satti is often cited by papers focused on Tuberculosis Research and Epidemiology (32 papers), Immune responses and vaccinations (20 papers) and Immunodeficiency and Autoimmune Disorders (17 papers). Iman Satti collaborates with scholars based in United Kingdom, South Africa and Netherlands. Iman Satti's co-authors include Helen McShane, Joel N. Meyer, Stephanie A. Harris, Ian Poulton, Helen A. Fletcher, Angela M. Minassian, Lisa Stockdale, Zita‐Rose Manjaly Thomas, Rachel Tanner and Raquel Lopez Ramon and has published in prestigious journals such as Nature Communications, PLoS ONE and American Journal of Respiratory and Critical Care Medicine.

In The Last Decade

Iman Satti

40 papers receiving 1.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Iman Satti United Kingdom	21	741	634	427	172	137	43	1.1k
Rosemary E. Weir United Kingdom	18	824 1.1×	736 1.2×	471 1.1×	111 0.6×	57 0.4×	26	1.2k
Lisa Stockdale United Kingdom	16	422 0.6×	320 0.5×	249 0.6×	119 0.7×	95 0.7×	35	684
Annelies W. Mesman United States	15	395 0.5×	302 0.5×	452 1.1×	137 0.8×	47 0.3×	24	873
Haiyan Wu China	4	376 0.5×	431 0.7×	268 0.6×	333 1.9×	142 1.0×	7	900
Azra Blazevic United States	13	524 0.7×	845 1.3×	507 1.2×	156 0.9×	33 0.2×	26	1.2k
Alison Han United States	14	293 0.4×	217 0.3×	500 1.2×	101 0.6×	102 0.7×	24	811
Shewangizaw Worku Sweden	9	291 0.4×	431 0.7×	382 0.9×	85 0.5×	168 1.2×	10	756
David J. C. Miles United Kingdom	20	253 0.3×	384 0.6×	402 0.9×	106 0.6×	117 0.9×	32	1.0k
Wivine Burny Belgium	16	269 0.4×	438 0.7×	293 0.7×	179 1.0×	36 0.3×	27	841
Jamila Ismaili Belgium	17	186 0.3×	857 1.4×	339 0.8×	143 0.8×	179 1.3×	25	1.2k

Countries citing papers authored by Iman Satti

Since Specialization

Citations

This map shows the geographic impact of Iman Satti's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Iman Satti with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Iman Satti more than expected).

Fields of papers citing papers by Iman Satti

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Iman Satti. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Iman Satti. The network helps show where Iman Satti may publish in the future.

Co-authorship network of co-authors of Iman Satti

This figure shows the co-authorship network connecting the top 25 collaborators of Iman Satti. A scholar is included among the top collaborators of Iman Satti based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Iman Satti. Iman Satti is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Marshall, Julia L., Iman Satti, Stephanie A. Harris, et al.. (2025). Early mucosal responses following a randomised controlled human inhaled infection with attenuated Mycobacterium bovis BCG. Nature Communications. 16(1). 4989–4989. 1 indexed citations

Almujri, Salem Salman, Elena Stylianou, Annalisa Nicastri, et al.. (2025). MetE: a promising protective antigen for tuberculosis vaccine development. Frontiers in Immunology. 16. 1593263–1593263.

Audran, R, et al.. (2024). Randomised, double-blind, controlled phase 1 trial of the candidate tuberculosis vaccine ChAdOx1-85A delivered by aerosol versus intramuscular route. Journal of Infection. 89(2). 106205–106205. 5 indexed citations

Satti, Iman, Andrew White, Karin Dijkman, et al.. (2024). Mtb-Specific HLA-E-Restricted T Cells Are Induced during Mtb Infection but Not after BCG Administration in Non-Human Primates and Humans. Vaccines. 12(10). 1129–1129. 2 indexed citations

Álvarez, Marco Polo Peralta, Andrew White, Stephanie A. Harris, et al.. (2024). Intravenous BCG vaccination in non-human primates induces superior serum antibody titers with enhanced avidity and opsonizing capacity compared to the intradermal route. Vaccine. 42(26). 126444–126444. 1 indexed citations

Satti, Iman, Stephanie A. Harris, Hazel Morrison, et al.. (2024). Evaluation of immune profiles associated with control of mycobacterial growth in systemic lupus erythematosus (SLE) patients. Tuberculosis. 148. 102533–102533. 1 indexed citations

Harris, Stephanie A., Hazel Morrison, Beatrice Nassanga, et al.. (2024). A dose escalation study to evaluate the safety of an aerosol BCG infection in previously BCG-vaccinated healthy human UK adults. Frontiers in Immunology. 15. 1427371–1427371.

Satti, Iman, Shuailin Li, Stephanie A. Harris, et al.. (2022). Inflammation and immune activation are associated with risk of Mycobacterium tuberculosis infection in BCG-vaccinated infants. Nature Communications. 13(1). 6594–6594. 14 indexed citations

Tanner, Rachel, Iman Satti, Stephanie A. Harris, et al.. (2020). Tools for Assessing the Protective Efficacy of TB Vaccines in Humans: in vitro Mycobacterial Growth Inhibition Predicts Outcome of in vivo Mycobacterial Infection. Frontiers in Immunology. 10. 2983–2983. 21 indexed citations

10.

Wilkie, Morven, Iman Satti, Alice Minhinnick, et al.. (2019). A phase I trial evaluating the safety and immunogenicity of a candidate tuberculosis vaccination regimen, ChAdOx1 85A prime – MVA85A boost in healthy UK adults. Vaccine. 38(4). 779–789. 63 indexed citations

11.

Smith, Steven G., Stephanie A. Harris, Iman Satti, et al.. (2017). Assay optimisation and technology transfer for multi-site immuno-monitoring in vaccine trials. PLoS ONE. 12(10). e0184391–e0184391. 5 indexed citations

12.

Harris, Stephanie A., Andrew White, Lisa Stockdale, et al.. (2017). Development of a non-human primate BCG infection model for the evaluation of candidate tuberculosis vaccines. Tuberculosis. 108. 99–105. 21 indexed citations

13.

Satti, Iman, Shannon L. Harris, Michael Riste, et al.. (2016). A Phase I Trial Evaluating Aerosol Administration Of A Candidate Tb Vaccine, Mva85a, As A Way To Induce Potent Local Cellular Immune Responses And Avoid Anti-Vector Immunity. American Journal of Respiratory and Critical Care Medicine. 193. 1 indexed citations

14.

Smith, Steven G., Simone A. Joosten, Krista E. van Meijgaarden, et al.. (2015). Intracellular Cytokine Staining and Flow Cytometry: Considerations for Application in Clinical Trials of Novel Tuberculosis Vaccines. PLoS ONE. 10(9). e0138042–e0138042. 51 indexed citations

15.

Minhinnick, Alice, Stephanie A. Harris, Morven Wilkie, et al.. (2015). Optimization of a Human Bacille Calmette-Guérin Challenge Model: A Tool to Evaluate Antimycobacterial Immunity. The Journal of Infectious Diseases. 213(5). 824–830. 26 indexed citations

16.

Satti, Iman, Joel N. Meyer, Stephanie A. Harris, et al.. (2014). Safety and immunogenicity of a candidate tuberculosis vaccine MVA85A delivered by aerosol in BCG-vaccinated healthy adults: a phase 1, double-blind, randomised controlled trial. The Lancet Infectious Diseases. 14(10). 939–946. 130 indexed citations

17.

Meyer, Joel N., Iman Satti, Leanne Marsay, et al.. (2013). Evaluation of a Human BCG Challenge Model to Assess Antimycobacterial Immunity Induced by BCG and a Candidate Tuberculosis Vaccine, MVA85A, Alone and in Combination. The Journal of Infectious Diseases. 209(8). 1259–1268. 59 indexed citations

18.

Rowland, Rosalind, Ansar A. Pathan, Iman Satti, et al.. (2012). Safety and immunogenicity of an FP9-vectored candidate tuberculosis vaccine (FP85A), alone and with candidate vaccine MVA85A in BCG-vaccinated healthy adults. Human Vaccines & Immunotherapeutics. 9(1). 50–62. 21 indexed citations

19.

Satti, Iman, Ahmed Hassan, Eltahir Awad Gasim Khalil, & Hannah Akuffo. (2002). The effect of repeated leishmanin skin testing on the immune responses to Leishmania antigen in healthy volunteers. Transactions of the Royal Society of Tropical Medicine and Hygiene. 96(5). 565–567. 12 indexed citations

20.

Maasho, Kerima, et al.. (2000). ALeishmaniaHomologue of Receptors for Activated C‐Kinase (LACK) Induces Both Interferon‐γ and Interleukin‐10 in Natural Killer Cells of Healthy Blood Donors. The Journal of Infectious Diseases. 182(2). 570–578. 33 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact